Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Meaningful aspects of the term 'mood stabilizer'.

Rybakowski JK.

Bipolar Disord. 2018 Jun;20(4):391-392. doi: 10.1111/bdi.12608. Epub 2018 Jan 12. No abstract available.

PMID:
29327794
2.

What is a mood stabilizer?

Goodwin GM, Malhi GS.

Psychol Med. 2007 May;37(5):609-14. Epub 2006 Dec 13. Review.

PMID:
17164028
3.

On defining 'mood stabilizer'.

Ghaemi SN.

Bipolar Disord. 2001 Jun;3(3):154-8. No abstract available.

PMID:
11465676
4.

What makes a drug a primary mood stabilizer?

Keck PE Jr, McElroy SL, Richtand N, Tohen M.

Mol Psychiatry. 2002;7 Suppl 1:S8-14. Review.

5.

Why 'mood stabilizer' needs stability: Polar views on its utility.

Malhi GS, Chengappa KNR.

Bipolar Disord. 2017 Sep;19(6):414-416. doi: 10.1111/bdi.12562. No abstract available.

PMID:
29065252
6.

Mood stabilization in the treatment of bipolar disorder: focus on quetiapine.

Vieta E.

Hum Psychopharmacol. 2005 Jun;20(4):225-36. Review. Erratum in: Hum Psychopharmacol. 2005 Jul;20(5):375.

PMID:
15880391
7.
8.
9.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

10.

Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation.

Viguera AC, Whitfield T, Baldessarini RJ, Newport DJ, Stowe Z, Reminick A, Zurick A, Cohen LS.

Am J Psychiatry. 2007 Dec;164(12):1817-24; quiz 1923.

PMID:
18056236
11.

What is a "mood stabilizer"? An evidence-based response.

Bauer MS, Mitchner L.

Am J Psychiatry. 2004 Jan;161(1):3-18. Review.

PMID:
14702242
12.

Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial.

Bowden CL, Vieta E, Ice KS, Schwartz JH, Wang PP, Versavel M.

J Clin Psychiatry. 2010 Feb;71(2):130-7. doi: 10.4088/JCP.09m05482yel. Epub 2010 Jan 26.

PMID:
20122373
13.

Comparative efficacy and acceptability of combined antipsychotics and mood stabilizers versus individual drug classes for acute mania: Network meta-analysis.

Glue P, Herbison P.

Aust N Z J Psychiatry. 2015 Dec;49(12):1215-20. doi: 10.1177/0004867415614109. Epub 2015 Nov 6. Review.

PMID:
26546499
14.

Is the combination of a mood stabilizer plus an antipsychotic more effective than mono-therapies in long-term treatment of bipolar disorder? A systematic review.

Buoli M, Serati M, Altamura AC.

J Affect Disord. 2014 Jan;152-154:12-8. doi: 10.1016/j.jad.2013.08.024. Epub 2013 Aug 31. Review.

PMID:
24041717
15.

Evidence questioning cromolyn's effectiveness and selectivity as a 'mast cell stabilizer' in mice.

Oka T, Kalesnikoff J, Starkl P, Tsai M, Galli SJ.

Lab Invest. 2012 Oct;92(10):1472-82. doi: 10.1038/labinvest.2012.116. Epub 2012 Aug 20.

16.

Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression.

Young LT, Joffe RT, Robb JC, MacQueen GM, Marriott M, Patelis-Siotis I.

Am J Psychiatry. 2000 Jan;157(1):124-6.

PMID:
10618026
17.

Regularity in daily mood stabilizer dosage taken by patients with bipolar disorder.

Bauer M, Glenn T, Alda M, Sagduyu K, Marsh W, Grof P, Munoz R, Baethge C, Lewitzka U, Pilhatsch M, Bauer R, Whybrow PC.

Pharmacopsychiatry. 2013 Jul;46(5):163-8. doi: 10.1055/s-0033-1343398. Epub 2013 Jun 24.

PMID:
23797414
18.

Clinical indicators for the use of antidepressants in the treatment of bipolar I depression.

Fagiolini A, Frank E, Cherry CR, Houck PR, Novick DM, Buysse DJ, Kupfer DJ.

Bipolar Disord. 2002 Oct;4(5):277-82.

PMID:
12479658
19.

[Case constitution and medication intention of bipolar disordered outpatients at two grade IIIa hospitals in Beijing].

Yan AG, Jia HX, Ma QF, Tian JZ, Shi J.

Zhonghua Yi Xue Za Zhi. 2013 Feb 26;93(8):594-6. Chinese.

PMID:
23663339
20.

[Olanzapine: a second generation antipsychotic drug and an "atypical" mood stabilizer?].

Bánki CM.

Psychiatr Hung. 2007;22(4):311-20. Review. Hungarian.

PMID:
18167425

Supplemental Content

Support Center